<div id="readability-page-1">02:02 PM EST, 03/02/2026 (MT Newswires) -- Health care stocks declined Monday afternoon with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each dropping 1.2%.The iShares Biotechnology ETF (IBB) shed 1.1%.In corporate news, uniQure (QURE) shares tumbled 33% after the US Food and Drug Administration said data from the company's Phase 1/2 trials was not sufficient to provide the primary evidence of effectiveness needed to support a marketing application for AMT-130, an investigational gene therapy for Huntington's disease.Zoetis ( ZTS ) agreed to buy Neogen's (NEOG) animal genomics business for $160 million. Neogen shares fell 0.7%, and Zoetis ( ZTS ) dropped 2%.Gyre Therapeutics ( GYRE ) shares climbed 7.4% after the company agreed to acquire clinical-stage biopharmaceutical company Cullgen for $300 million in stock. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

QURE

ARKG

Health care stocks fell on Monday, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) down 1.2%. The iShares Biotechnology ETF (IBB) decreased by 1.1%. Notably, uniQure (QURE) shares plummeted 33% after the FDA deemed their trial data insufficient for a marketing application for AMT-130. Zoetis (ZTS) announced a $160 million acquisition of Neogen's (NEOG) animal genomics business, while Gyre Therapeutics (GYRE) shares rose 7.4% following their agreement to acquire Cullgen for $300 million in stock.

fidelity

Uniqure

Ark Genomic Revolution ETF

SPDR S&P Biotech

VG Health

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

Neogen

Direxion S&P Biotech Bear 3X

iShares US Pharma

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

iShares Genomics Immunology and Healthcare ETF

iShares US Medical Devices

Gyre Therapeutics

Health Care Select Sector SPDR

iShares Global Healthcare

SPDR S&P Health Equip

Sector Update: Health Care Stocks Retreat Monday Afternoon